S&P・Nasdaq 本質的価値 お問い合わせ

NEXGEL, Inc. NXGLW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
34/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

NEXGEL, Inc. (NXGLW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $-0.54 および 売上高 $0.01B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $-0.50 vs 予想 $-0.54 (上回る +7.4%). 2025: 実績 $-0.38 vs 予想 $-0.35 (下回る -8.6%). アナリスト精度: 92%.

EPS予測 — NXGLW

92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.50 vs Est –$0.54 ▲ 8.0% off
2025 Actual –$0.38 vs Est –$0.35 ▼ 7.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

売上高予測 — NXGLW

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.009B vs Est $0.009B ▲ 0.6% off
2025 Actual $0.011B vs Est $0.012B ▼ 3.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る